Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 2200
Species: Rattus norvegicus
RGD Object: Gene
Symbol: Bcl2l1
Name: Bcl2-like 1
Acc ID: CHEBI:4031
Term: cyclosporin A
Definition: A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.
Chemical ID: MESH:D016572
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
Bcl2l1affects expressionISOBCL2L1 (Homo sapiens)6480464CTDCyclosporine affects the expression of BCL2L1 mRNAPMID:20106945
Bcl2l1decreases expressionISOBCL2L1 (Homo sapiens)6480464CTDCyclosporine results in decreased expression of BCL2L1 mRNAPMID:21632981
Bcl2l1increases expressionISOBCL2L1 (Homo sapiens)6480464CTDCyclosporine results in increased expression of BCL2L1 mRNAPMID:25562108
Bcl2l1multiple interactionsISOBcl2l1 (Mus musculus)6480464CTDCyclosporine inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in decreased expression of BCL2L1 protein]PMID:37308051
Bcl2l1multiple interactionsISOBCL2L1 (Homo sapiens)6480464CTD[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of BCL2L1 mRNAPMID:33819548
Go Back to source page   Continue to Ontology report